Impact of subsequent therapy on survival in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as first-line therapy for advanced urothelial carcinoma (UC).

Alva A. S., Csoszi T., ÖZGÜROĞLU M., Matsubara N., Geczi L., Cheng S. Y., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.6, 2021 (SCI-Expanded)

  • Publication Type: Article / Abstract
  • Volume: 39 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.1200/jco.2021.39.6_suppl.439
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Akdeniz University Affiliated: No